Press Releases Archives - Page 14 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin and Fuji Sign License and Supply Agreement for Commercialization of Nextstellis™ in Vietnam and Philippines

Lupin Completes Acquisition of two Brands from Sanofi in Europe and Canada

Lupin Receives Tentative Approval from U.S. FDA for Letermovir Tablets

Lupin Launches Doxycycline for Injection USP in the United States

Lupin Receives Approval from U.S. FDA for Midostaurin Capsules

Lupin Achieves Significant Milestone with ISO 14001 and ISO 45001 Certification Across All its Indian Manufacturing Sites, R&D Center and Corporate Office

Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors

Lupin Q4 FY2024 Results

Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP

Lupin Launches Rymti® Biosimilar Etanercept in Canada

1 2 … 13 14 15 … 102 103

Search

Hit enter to search or ESC to close